BlackRock Fund Advisors - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 188 filers reported holding ACORDA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 1.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$81,030,000
+5.4%
4,310,090
+17.0%
0.02%
-6.2%
Q3 2016$76,903,000
-11.9%
3,683,111
+7.6%
0.02%
-15.8%
Q2 2016$87,322,000
-1.5%
3,423,735
+2.1%
0.02%
-9.5%
Q1 2016$88,660,000
-35.0%
3,352,000
+5.1%
0.02%
-32.3%
Q4 2015$136,484,000
+63.1%
3,190,370
+1.1%
0.03%
+40.9%
Q3 2015$83,662,000
-17.1%
3,155,864
+4.3%
0.02%
-8.3%
Q2 2015$100,865,000
+0.9%
3,026,243
+0.8%
0.02%0.0%
Q1 2015$99,955,000
-13.3%
3,003,445
+6.5%
0.02%
-14.3%
Q4 2014$115,223,000
+30.8%
2,819,253
+8.4%
0.03%
+12.0%
Q3 2014$88,104,000
-1.5%
2,600,475
-2.0%
0.02%0.0%
Q2 2014$89,410,000
-15.6%
2,652,333
-5.1%
0.02%
-19.4%
Q1 2014$105,952,000
+32.8%
2,794,835
+2.3%
0.03%
+29.2%
Q4 2013$79,784,000
-11.6%
2,732,320
+3.6%
0.02%
-20.0%
Q3 2013$90,222,000
+18.1%
2,638,060
+13.9%
0.03%
+7.1%
Q2 2013$76,410,0002,316,1600.03%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
PFM Health Sciences, LP 1,526,174$1,423,0000.12%
GSA CAPITAL PARTNERS LLP 250,271$233,0000.06%
Spark Investment Management LLC 110,300$102,0000.05%
SALZHAUER MICHAEL 30,000$28,0000.05%
HAP Trading, LLC 260,800$532,0000.04%
Point72 Asset Management, L.P. 1,589,600$1,482,0000.01%
DLD Asset Management, LP 208,400$196,0000.01%
ACADIAN ASSET MANAGEMENT LLC 1,893,678$1,765,0000.01%
EVERENCE CAPITAL MANAGEMENT INC 65,680$61,0000.01%
Benin Management CORP 11,714$11,0000.01%
View complete list of ACORDA THERAPEUTICS INC shareholders